Genetic Testing / Preimplantation Genetic Testing for Aneuploidies (PGTA)
Preimplantation Genetic Testing for Aneuploidies (PGTA) is an advanced genetic screening process used in conjunction with IVF. PGTA analyzes the chromosomal makeup of embryos before transfer to the uterus, ensuring only chromosomally normal (euploid) embryos are selected for implantation. By identifying and selecting these healthy embryos, PGTA significantly enhances the chances of a successful pregnancy and reduces the risk of miscarriage, especially in individuals and couples with known genetic conditions or a history of recurrent pregnancy loss.
Whom is PGTA For?
PGTA is recommended for patients who:
- Are advanced maternal age (women over 35)
- Have a history of multiple miscarriages or recurrent IVF failures
- Are carriers of chromosomal abnormalities
- Seek to minimize the risk of genetic disorders
PGTA Process
- IVF and Embryo Creation: Following the IVF process, embryos are created in the lab from fertilized eggs.
- Embryo Biopsy: A small sample of cells is carefully removed from each embryo at the blastocyst stage.
- Genetic Testing: These cells are analyzed to detect any chromosomal abnormalities, focusing on the number of chromosomes.
- Selection and Transfer: Only chromosomally healthy embryos are selected for transfer to the uterus, enhancing the likelihood of a successful pregnancy.
Success Rates and Advantages
PGTA greatly improves the chances of a successful pregnancy and reduces the risk of miscarriage by identifying and selecting healthy embryos. It’s a particularly valuable option for those at risk for chromosomal abnormalities or with a history of unsuccessful pregnancies. At Embryonic Fertility, we use state-of-the-art genetic testing technology to provide the most accurate results possible, giving our patients greater peace of mind and an enhanced chance at a successful outcome.
Advantages of PGTA
- Higher Implantation Rates: PGTA helps in selecting the embryos with the highest potential, increasing implantation rates.
- Reduced Risk of Genetic Disorders: By identifying chromosomal abnormalities, PGTA helps in reducing the risk of genetic disorders in offspring.
- Lower Miscarriage Rates: Selecting only euploid embryos reduces the risk of miscarriage, offering a safer path to a healthy pregnancy.
- Improved IVF Efficiency: PGTA enhances the overall success rates of IVF by ensuring only viable embryos are transferred, saving time and emotional energy for patients.
Is PGTA Right for You?
PGTA is especially beneficial for older women, individuals with genetic predispositions, or couples with a history of unsuccessful IVF cycles. Our specialists at Embryonic Fertility can help determine if PGTA is the right choice based on your unique medical history and fertility journey.